News & Analysis as of

Supply Chain Research and Development

Foley & Lardner LLP

BIOSECURE Act: Anticipated Movement, Key Provisions, and Likely Impact

Foley & Lardner LLP on

Last night, the House of Representatives passed the BIOSECURE Act (BIOSECURE or the Act) by a bipartisan vote of 306 to 81.  The BIOSECURE Act prohibits federal agencies from procuring or obtaining any biotechnology...more

McDermott Will & Emery

Pharma and MedTech Services Investment Summit 2024

McDermott Will & Emery on

The inaugural Pharma and MedTech Services Investment Summit brought together C-suite executives, senior private equity professionals, investment bankers and other industry leaders for a deep dive into the investment...more

Akin Gump Strauss Hauer & Feld LLP

This Week’s Climate Policy Update - May 2024 #2

Good afternoon! This is Akin’s newsletter on climate change policy and regulatory developments, providing information on major climate policy headlines from the past week and forthcoming climate-related events and hearings...more

McDermott Will & Emery

[Event] Pharma and MedTech Services Investment Summit 2024 - May 2nd, San Francisco, CA

McDermott Will & Emery on

YOUR SOURCE FOR SUCCESS IN PHARMA AND DEVICE SERVICES INVESTING - Join C-suite executives, senior private equity professionals, investment bankers and other industry leaders for a deep dive into the investment...more

Holland & Knight LLP

Capturing Industrial Base from the DoD

Holland & Knight LLP on

With ever-increasing threats from the Chinese Communist Party, recently exposed vulnerabilities in the United States' supply chain and decades of outsourcing that has left the defense and industrial base vulnerable, there is...more

Perkins Coie

BARDA Shares Details About Innovative BioMaP Consortium at BARDA Industry Day 2023

Perkins Coie on

The Biomedical Advanced Research and Development Authority (BARDA) held its first in-person BARDA Industry Day (BID) since the beginning of the COVID-19 pandemic in Washington, D.C., on November 13-14, 2023. BID is an annual...more

Woodruff Sawyer

How to Manage Exposures When Commercializing a Life Sciences Product

Woodruff Sawyer on

The road to commercializing a life sciences product is a long one, spanning years to perform research, develop the product, conduct clinical trials and testing, and receive approval from the Food and Drug Administration...more

NAVEX

Risk Management 101: The Human Touch

NAVEX on

In the first part of Risk Management 101, we focused on the foundational elements of risk management. In part two, we’ll look at how the people who keep your organization running, with their unique insights, skills and...more

K2 Integrity

Post-Pandemic Era: Understanding the CHIPS and Science Act of 2022 and Its Impact on the Construction Industry

K2 Integrity on

The COVID-19 pandemic created unprecedented challenges in technology, with the demand for equipment increasing dramatically as the world quickly transitioned into remote operations. During this time, the United States’...more

Dechert LLP

Follow the Money: The CHIPS and Science Act’s (Limited) Outbound Review Mechanism

Dechert LLP on

Key Takeaways The CHIPS Program Office of the U.S. Department of Commerce's National Institute of Standards and Technology (“NIST”) proposed a rule that describes the expected procedure for reviewing outbound investments...more

Hogan Lovells

CHIPS Act Funding window now open for U.S. semiconductor industry

Hogan Lovells on

The CHIPS and Science Act of 2022 is offering US$52.7 billion in federal funding to semiconductor research, development, and manufacturing. Three funding opportunities are currently available as of February 28, 2023, and two...more

Wiley Rein LLP

Wireless Roundup (November 2022)

Wiley Rein LLP on

SEC Requests Comment on Incident Reporting NPRM for Certain Filings Affected by Technical Glitch: On October 18, the Securities and Exchange Commission (SEC) published a Notice announcing it has re-opened for 14 days the...more

Akin Gump Strauss Hauer & Feld LLP

NIST Seeks Public Comment on CHIPS Implementation Program

Key Points - NIST is soliciting input from the public to inform the design and implementation of the CHIPS incentive programs and research and development investments in Manufacturing USA institutes. Comments are due to...more

White & Case LLP

Decarbonizing in a downturn: Can the mining & metals sector afford (not) to change?

White & Case LLP on

Softening commodity prices and economic headwinds may deter miners and metal companies from deploying the significant capital expenditure required to decarbonize....more

Dorsey & Whitney LLP

The CHIPS and Sciences ACT of 2022 - The Impact on China

Dorsey & Whitney LLP on

The CHIPS and Sciences Act of 2022 (the “Act”) was passed by the U.S. Congress on July 27, 2022 and signed into law by President Biden on August 9 of the same year. The Act is an effort to increase semiconductor manufacturing...more

Orrick, Herrington & Sutcliffe LLP

CHIPS Act: What Companies Need to Know

On August 9, 2022, President Biden signed into law the highly anticipated CHIPS Act of 2022 (the “CHIPS Act”). Presented as being crucial to ensuring U.S. leadership in global chip production and technical capability against...more

Akin Gump Strauss Hauer & Feld LLP

Chips-Plus Artificial Intelligence in the CHIPS Act of 2022

On August 9, 2022, President Biden signed the CHIPS Act of 2022 (the “Act”), legislation to fund domestic semiconductor manufacturing and boost federal scientific research and development (see our previous alert for...more

Morrison & Foerster LLP - Government...

CHIPS And Science Act Makes Available Billions Of Dollars For The United States Science And Technology Sectors

Infusing billions of dollars into the U.S. semiconductor industry and appropriating billions more for scientific research and development, what is now colloquially referred to as the CHIPS and Science Act of 2022 was signed...more

White & Case LLP

President Biden Signs CHIPS and Science Act into Law

White & Case LLP on

On August 9, 2022, President Biden signed the CHIPS and Science Act (H.R.4346), which seeks to bolster the US semiconductor supply chain and promote research and development of advanced technologies in the United States. The...more

Pillsbury Winthrop Shaw Pittman LLP

Historic $280 Billion Investment in Domestic Semiconductor Manufacturing and STEM Research and Development to Be Signed into Law

The legislation is the result of months of negotiations between Congressional Democrats and Republicans to support domestic semiconductor manufacturing and related research and workforce development efforts. The topline...more

Akin Gump Strauss Hauer & Feld LLP

Senate Passes Chips-Plus Package, House Passage Imminent

In a bipartisan vote of 64-33, the Senate passed legislation earlier today to fund domestic semiconductor manufacturing and boost federal scientific research and development. The bill was supported by 17 Republicans and...more

Jones Day

Japan Enacts Economic Security Law

Jones Day on

The Japanese parliament has enacted the first comprehensive economic security legislation to enhance Japan's national security from an economic activities perspective, especially focusing on sensitive industry sectors such as...more

King & Spalding

U.S. Department of Energy Releases Report on Securing America’s Clean Energy Supply Chain

King & Spalding on

DEPARTMENT OF ENERGY PROPOSES SEVERAL POLICY ACTIONS TO OVERCOME ENERGY SUPPLY CHAIN CHALLENGES AND TRANSITION TO CLEAN ENERGY - This is the second in a series of client alerts that will be published in the near future...more

Akin Gump Strauss Hauer & Feld LLP

House GOP Policy Priorities Going Forward: Tax Policies to Support Domestic Research, Development, and Manufacturing of Treatment...

On Monday, April 18, 2022, Reps. Vern Buchanan (R-FL), Mike Kelly (R-PA) and Brad Wenstrup (R-OH)—all Republican Members of the House Committee on Ways & Means—reintroduced several pieces of legislation meant to secure...more

Kohrman Jackson & Krantz LLP

Congress Aims To Fund Domestic Technology Businesses

Last week, just days ahead of the March 11 funding deadline, President Biden signed into law a $1.5 trillion Omnibus budget, the Consolidated Appropriations Act of 2022, to fund federal agencies for the rest of the year....more

51 Results
 / 
View per page
Page: of 3

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide